CELLECTIS (ALCLS) Insider Transactions
Track insider buying and selling at CELLECTIS. 4 transactions on record from official AMF filings.
Last updated: 2026-06-19 · Data sourced from MAR Article 19 regulatory disclosures
Recent Insider Transactions at CELLECTIS
| Date | Insider | Role | Type | Shares | Price | Value | Signals |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | David Sourdive | Vice Chairman | SELL | 5,875 | €3 | €17.9K | — |
| 2026-06-01 | David Sourdive | Vice Chairman | SELL | 62,083 | €3 | €199.1K | — |
| 2026-06-01 | David Sourdive | Vice Chairman | SELL | 50,000 | €3 | €157.5K | — |
| 2026-06-01 | David Sourdive | Vice Chairman | SELL | 32,042 | €3 | €100.3K | — |
Showing last 4 transactions · View all in app →
Live filings with conviction scores, signal badges, and post-trade return tracking.
Insiders Tracked at CELLECTIS
About This Data
InsidersAlpha tracks insider transactions at CELLECTIS filed with AMF under MAR Article 19. Data is sourced directly from official regulatory filings and updated daily. All 4 transactions on record include 0 insider purchases and 4 sales.
The largest single transaction recorded was worth €199.1K by David Sourdive on 2026-06-01.
Frequently Asked Questions
Who are the insiders trading CELLECTIS stock?
Known insiders at CELLECTIS include David Sourdive (Vice Chairman). InsidersAlpha tracks 1 named insider at CELLECTIS.
When was the last insider buy at CELLECTIS?
The most recent insider filing at CELLECTIS was recorded on 2026-06-02. InsidersAlpha updates daily from official AMF disclosures.
How many insider transactions has CELLECTIS had?
CELLECTIS has had 4 insider transactions tracked on InsidersAlpha, including 0 purchases and 4 sales. The overall buy/sell ratio is 0% buys.
What is the insider buying trend at CELLECTIS?
Over the past 6 months, CELLECTIS insiders have made 0 purchases totaling —. The insider activity trend is bearish — insiders are predominantly selling (0 buys vs 4 sells). Past performance does not guarantee future results — always conduct your own research.